Page 7 - Pfizer

Booster shots for 40+ and frontline workers to cost govt another Rs 10k cr

If booster shots are given on priority, the pace of vaccination may slow further. In the worst case scenario, the country will take till mid-March to vaccinate its entire adult population partially.

Pfizer's Covid-19 antiviral pill marks significant step forward: Biden

US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic.

Pfizer Covid pill nearly 90% effective, works on Omicron, shows lab data

The updates come as Covid cases, deaths and hospitalization are all rising again and the US hovers around 800,000 pandemic deaths

Top headlines: PCA framework for NBFCs; Nov WPI inflation spikes to 14.23%

Business Standard brings you the top headlines on Tuesday

Two doses of Covid vax induce lower antibody levels against Omicron: Study

Two doses of Pfizer AstraZeneca Covid vaccines generate lower levels of antibodies against the Omicron variant of coronavirus.

Pfizer to acquire Arena Pharmaceuticals at 100% premium in $6.7-bn deal

The U.S. drugmaker will pay $100 a share in an all-cash transaction for San Diego-based Arena, bringing assets in gastroenterology, dermatology and cardiology

Booster shot of Pfizer can cut mortality from Delta variant by 90%: Study

The third dose of the Pfizer Covid-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel.

Three-shot course of Pfizer's Covid-19 vaccine neutralises Omicron variant

BioNTech and Pifzer are the first manufacturers of a Covid vaccine to issue an official update on the efficacy of their shot against Omicron

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

A booster with the current version of the vaccine increased antibodies 25-fold, providing a similar level as observed after two doses

Pfizer vaccine may only partially protect against Omicron variant: Study

South Africa research shows that blood from people who had received two doses of the vaccine and had a prior infection were mostly able to neutralise the variant.

Pfizer faces scrutiny over scale of its Covid profits, says report

Pfizer has to date pledged 40m doses out of global production to Covax

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines.

Delta variant may have increased ability to evade vaccine immunity: Study

Vaccines are effective in decreasing hospitalization and deaths from Covid-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a recent study.

UK study finds mRNA Covid-19 vaccines provide biggest booster impact

Pfizer and Moderna shots give large antibody boosts regardless of whether a person initially received those vaccines.

Pfizer working on updated jab in response to Omicron variant: CEO

Pfizer's chief executive Dr Albert Bourla said he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease

Pfizer begins application for Canada's approval of Covid-19 pill

The country has identified seven people with the new variant as of Nov. 30.

Pfizer, BioNTech unsure of vax effectiveness against new Covid variant

The companies also promised to develop a new vaccine against the variant in about 100 days

LIVE: 25 killed, 17 missing as flash floods ravage Andhra Pradesh

In Kadiri town in Anantapuramu district, a building under construction collapsed due to incessant rain and fell on an adjoining one, killing at least five persons, including two children

Canada to allow entry to those vaccinated with Sinopharm, Sinovac, Covaxin

Currently, Canada only accepts travellers who have received the vaccines, including Pfizer, Moderna, AstraZeneca and Johnson and Johnson

FDA authorises Pfizer, Moderna Covid-19 vaccine boosters for US adults

The regulator's decision paves the way for millions of Americans to get additional protection